AwardedOCID: ocds-h6vhtk-05e9b3

Process and Impact Evaluation Phase 3 - Generation Study

To provide comprehensive process and impact evaluation services for the Newborns Genome Programme ("Generation Study"). The required services include conducting interviews with designers and early implementers of the Generation Study, administering surveys and follow-up interviews with parents twelve months after completion of the initial survey, and undertaking micro-costing analyses to assess changes in resource use and costs as the programme scales. All data collection and analysis shall be performed using approved qualitative and quantitative methods, under the oversight of the Study Advisory Group and the Patient and Public Involvement and Engagement (PPIE) Advisory Group.

Buyer
GENOMICS ENGLAND LIMITED
Contract Value
Value not disclosed
Deadline
No deadline set
Published
2 Feb 2026
Interactive

About This GENOMICS ENGLAND LIMITED Contract

This award stage contract from GENOMICS ENGLAND LIMITED was published in 2026. The Process and Impact Evaluation Phase 3 - Generation Study contract.

This UK government contract opportunity is part of the public procurement process, openly available via Find a Tender.

Contract Analytics

Key Metrics

0Match
0%
Match
50%
Urgency
30%
Value

Sector Distribution

General100%

Contract Timeline

2 Feb

Published

Current

Award Phase

Value Analysis

Contract value not disclosed

Market Activity

+15%

UK tender activity (12 months)

Process and Impact Evaluation Phase 3 - Generation Study - Scope of Work

0 phases • 0 requirements • 1 capabilities

Required Capabilities

data
  • To provide comprehensive process and impact evaluation services for the Newborns
  • Genome Programme ("Generation Study"). The required services include conducting
  • interviews with designers and early implementers of the Generation Study, administering
  • surveys and follow-up interviews with parents twelve months after completion of the initial
  • survey, and undertaking micro-costing analyses to assess changes in resource use and
  • costs as the programme scales. All data collection and analysis shall be performed using
  • approved qualitative and quantitative methods, under the oversight of the Study Advisory
  • Group and the Patient and Public Involvement and Engagement (PPIE) Advisory Group.

Ask the AI assistant for deeper analysis of this scope

Contract Value

Fixed PriceSingle contract value agreed upfront
Value not disclosed

Key Dates

Important deadlines and milestones

UK Time

Notice Published

Tender opportunity made public on Find a Tender

Mon, 2 Feb 2026
Passed

What This GENOMICS ENGLAND LIMITED Contract Means

For Citizens

This is a public procurement by GENOMICS ENGLAND LIMITED. All UK government contracts are publicly accessible for transparency.

For Businesses

This GENOMICS ENGLAND LIMITED contract has been awarded. Review for market intelligence.

Related Opportunities

Sector Overview

Buyer Network

Your Match Score

Complete your profile for personalized match scoring

Company Match Analysis

Analyze how well this tender matches your company profile and capabilities.

Market Activity

-6%

UK tender activity (12 months)

GENOMICS ENGLAND LIMITED

Contact Information

View All Contracts
GENOMICS ENGLAND LIMITED
Spending trends, sector breakdown & more →

Quick Facts

Stage
Award
Status
complete
CPV Codes
0

Reference ID

ocds-h6vhtk-05e9b3

Win More UK Government Contracts

RFP.quest helps UK businesses find and win public sector tenders. Our AI platform analyzes requirements, identifies gaps, and helps craft winning proposals.

UK tender data from Find a Tender under the Open Government Licence. Powered by RFP.quest.

Tender Assistant

I can help you understand this GENOMICS ENGLAND LIMITED contract:

• Requirements and evaluation criteria • Risks and gaps analysis • Buyer and market context • Related opportunities

Ask me anything about "Process and Impact Evaluation Phase 3 - Generation Study"!

Powered by CopilotKit